Free Trial

Exponent (EXPO) Competitors

Exponent logo
$69.81 +0.03 (+0.04%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$69.81 0.00 (-0.01%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EXPO vs. TRU, IT, BAH, ANDG, and PL

Should you buy Exponent stock or one of its competitors? Exponent's main competitors and comparable companies include TransUnion (TRU), Gartner (IT), Booz Allen Hamilton (BAH), Andersen Group (ANDG), and Planet Labs PBC (PL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "research & consulting services" industry.

How does Exponent compare to TransUnion?

Exponent (NASDAQ:EXPO) and TransUnion (NYSE:TRU) are both industrials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

Exponent has a net margin of 17.67% compared to TransUnion's net margin of 15.08%. Exponent's return on equity of 31.48% beat TransUnion's return on equity.

Company Net Margins Return on Equity Return on Assets
Exponent17.67% 31.48% 15.53%
TransUnion 15.08%16.29%6.67%

Exponent currently has a consensus price target of $81.00, indicating a potential upside of 16.03%. TransUnion has a consensus price target of $92.75, indicating a potential upside of 41.44%. Given TransUnion's stronger consensus rating and higher probable upside, analysts plainly believe TransUnion is more favorable than Exponent.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exponent
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
TransUnion
0 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.63

In the previous week, TransUnion had 6 more articles in the media than Exponent. MarketBeat recorded 10 mentions for TransUnion and 4 mentions for Exponent. Exponent's average media sentiment score of 0.61 beat TransUnion's score of 0.38 indicating that Exponent is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Exponent
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
TransUnion
4 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

TransUnion has higher revenue and earnings than Exponent. TransUnion is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Exponent$582.01M5.70$106.01M$2.2331.30
TransUnion$4.58B2.75$455.40M$3.7917.30

Exponent has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market. Comparatively, TransUnion has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market.

Exponent pays an annual dividend of $1.24 per share and has a dividend yield of 1.8%. TransUnion pays an annual dividend of $0.50 per share and has a dividend yield of 0.8%. Exponent pays out 55.6% of its earnings in the form of a dividend. TransUnion pays out 13.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Exponent has increased its dividend for 12 consecutive years and TransUnion has increased its dividend for 1 consecutive years. Exponent is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

92.4% of Exponent shares are held by institutional investors. 1.7% of Exponent shares are held by company insiders. Comparatively, 0.4% of TransUnion shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Exponent beats TransUnion on 10 of the 19 factors compared between the two stocks.

How does Exponent compare to Gartner?

Gartner (NYSE:IT) and Exponent (NASDAQ:EXPO) are both industrials companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

In the previous week, Gartner had 21 more articles in the media than Exponent. MarketBeat recorded 25 mentions for Gartner and 4 mentions for Exponent. Exponent's average media sentiment score of 0.61 beat Gartner's score of 0.25 indicating that Exponent is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Gartner
4 Very Positive mention(s)
7 Positive mention(s)
10 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Exponent
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

91.5% of Gartner shares are owned by institutional investors. Comparatively, 92.4% of Exponent shares are owned by institutional investors. 2.6% of Gartner shares are owned by company insiders. Comparatively, 1.7% of Exponent shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Gartner has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market. Comparatively, Exponent has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market.

Gartner has higher revenue and earnings than Exponent. Gartner is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gartner$6.46B1.87$729.23M$11.1517.14
Exponent$582.01M5.70$106.01M$2.2331.30

Gartner currently has a consensus price target of $189.00, indicating a potential downside of 1.13%. Exponent has a consensus price target of $81.00, indicating a potential upside of 16.03%. Given Exponent's stronger consensus rating and higher probable upside, analysts clearly believe Exponent is more favorable than Gartner.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Gartner
2 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00
Exponent
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

Exponent has a net margin of 17.67% compared to Gartner's net margin of 11.99%. Gartner's return on equity of 525.46% beat Exponent's return on equity.

Company Net Margins Return on Equity Return on Assets
Gartner11.99% 525.46% 13.45%
Exponent 17.67%31.48%15.53%

Summary

Exponent beats Gartner on 8 of the 15 factors compared between the two stocks.

How does Exponent compare to Booz Allen Hamilton?

Exponent (NASDAQ:EXPO) and Booz Allen Hamilton (NYSE:BAH) are both mid-cap industrials companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

In the previous week, Booz Allen Hamilton had 4 more articles in the media than Exponent. MarketBeat recorded 8 mentions for Booz Allen Hamilton and 4 mentions for Exponent. Exponent's average media sentiment score of 0.61 beat Booz Allen Hamilton's score of 0.18 indicating that Exponent is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Exponent
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Booz Allen Hamilton
1 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Exponent has a beta of 0.69, meaning that its share price is 31% less volatile than the broader market. Comparatively, Booz Allen Hamilton has a beta of 0.37, meaning that its share price is 63% less volatile than the broader market.

Booz Allen Hamilton has higher revenue and earnings than Exponent. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Exponent$582.01M5.70$106.01M$2.2331.30
Booz Allen Hamilton$11.22B0.79$851M$6.3611.63

92.4% of Exponent shares are held by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are held by institutional investors. 1.7% of Exponent shares are held by insiders. Comparatively, 1.1% of Booz Allen Hamilton shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Exponent presently has a consensus target price of $81.00, suggesting a potential upside of 16.03%. Booz Allen Hamilton has a consensus target price of $85.62, suggesting a potential upside of 15.70%. Given Exponent's stronger consensus rating and higher probable upside, research analysts clearly believe Exponent is more favorable than Booz Allen Hamilton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exponent
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Booz Allen Hamilton
4 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.00

Exponent has a net margin of 17.67% compared to Booz Allen Hamilton's net margin of 7.01%. Booz Allen Hamilton's return on equity of 76.71% beat Exponent's return on equity.

Company Net Margins Return on Equity Return on Assets
Exponent17.67% 31.48% 15.53%
Booz Allen Hamilton 7.01%76.71%11.48%

Exponent pays an annual dividend of $1.24 per share and has a dividend yield of 1.8%. Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 3.2%. Exponent pays out 55.6% of its earnings in the form of a dividend. Booz Allen Hamilton pays out 37.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Exponent has raised its dividend for 12 consecutive years and Booz Allen Hamilton has raised its dividend for 14 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Exponent beats Booz Allen Hamilton on 10 of the 19 factors compared between the two stocks.

How does Exponent compare to Andersen Group?

Exponent (NASDAQ:EXPO) and Andersen Group (NYSE:ANDG) are both mid-cap industrials companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

Exponent presently has a consensus target price of $81.00, suggesting a potential upside of 16.03%. Andersen Group has a consensus target price of $56.14, suggesting a potential downside of 1.26%. Given Exponent's higher possible upside, research analysts plainly believe Exponent is more favorable than Andersen Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exponent
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Andersen Group
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.50

Exponent has a net margin of 17.67% compared to Andersen Group's net margin of 0.00%. Exponent's return on equity of 31.48% beat Andersen Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Exponent17.67% 31.48% 15.53%
Andersen Group N/A N/A N/A

92.4% of Exponent shares are owned by institutional investors. 1.7% of Exponent shares are owned by insiders. Comparatively, 13.0% of Andersen Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Andersen Group had 2 more articles in the media than Exponent. MarketBeat recorded 6 mentions for Andersen Group and 4 mentions for Exponent. Exponent's average media sentiment score of 0.61 beat Andersen Group's score of 0.12 indicating that Exponent is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Exponent
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Andersen Group
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Exponent has higher earnings, but lower revenue than Andersen Group. Andersen Group is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Exponent$582.01M5.70$106.01M$2.2331.30
Andersen Group$838.69M7.66-$2.32M-$0.53N/A

Summary

Exponent beats Andersen Group on 9 of the 15 factors compared between the two stocks.

How does Exponent compare to Planet Labs PBC?

Exponent (NASDAQ:EXPO) and Planet Labs PBC (NYSE:PL) are both mid-cap industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

92.4% of Exponent shares are held by institutional investors. Comparatively, 41.7% of Planet Labs PBC shares are held by institutional investors. 1.7% of Exponent shares are held by company insiders. Comparatively, 16.4% of Planet Labs PBC shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Exponent presently has a consensus target price of $81.00, indicating a potential upside of 16.03%. Planet Labs PBC has a consensus target price of $31.56, indicating a potential upside of 83.60%. Given Planet Labs PBC's higher possible upside, analysts clearly believe Planet Labs PBC is more favorable than Exponent.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exponent
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Planet Labs PBC
1 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.43

Exponent has higher revenue and earnings than Planet Labs PBC. Planet Labs PBC is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Exponent$582.01M5.70$106.01M$2.2331.30
Planet Labs PBC$307.73M20.32-$246.86M-$1.10N/A

Exponent has a net margin of 17.67% compared to Planet Labs PBC's net margin of -95.13%. Exponent's return on equity of 31.48% beat Planet Labs PBC's return on equity.

Company Net Margins Return on Equity Return on Assets
Exponent17.67% 31.48% 15.53%
Planet Labs PBC -95.13%-93.11%-29.17%

In the previous week, Planet Labs PBC had 6 more articles in the media than Exponent. MarketBeat recorded 10 mentions for Planet Labs PBC and 4 mentions for Exponent. Exponent's average media sentiment score of 0.61 beat Planet Labs PBC's score of 0.40 indicating that Exponent is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Exponent
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Planet Labs PBC
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral

Exponent has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, Planet Labs PBC has a beta of 2.17, meaning that its stock price is 117% more volatile than the broader market.

Summary

Exponent beats Planet Labs PBC on 10 of the 17 factors compared between the two stocks.

Get Exponent News Delivered to You Automatically

Sign up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EXPO vs. The Competition

MetricExponentProfessional Services IndustryIndustrials SectorNASDAQ Exchange
Market Cap$3.32B$7.79B$10.12B$13.21B
Dividend Yield1.78%3.75%96.64%16.37%
P/E Ratio31.3037.1726.6726.16
Price / Sales5.7024.32267.96113.01
Price / Cash29.9922.1223.8353.09
Price / Book8.936.934.776.34
Net Income$106.01M$236.73M$615.96M$381.90M
7 Day Performance3.73%1.83%-1.12%-1.41%
1 Month Performance3.68%-0.79%-2.21%-3.48%
1 Year Performance6.96%-8.66%3.20%1.16%

Exponent Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EXPO
Exponent
4.5572 of 5 stars
$69.81
+0.0%
$81.00
+16.0%
+6.9%$3.32B$582.01M31.301,212
TRU
TransUnion
4.3253 of 5 stars
$64.00
+0.9%
$92.75
+44.9%
-17.0%$12.16B$4.58B16.8913,500
IT
Gartner
3.7165 of 5 stars
$187.97
+1.7%
$188.50
+0.3%
-21.8%$11.67B$6.50B16.8620,244
BAH
Booz Allen Hamilton
3.8354 of 5 stars
$68.76
+2.1%
$83.69
+21.7%
-25.6%$8.10B$11.09B10.8131,500
ANDG
Andersen Group
1.801 of 5 stars
$56.09
-1.8%
$56.14
+0.1%
N/A$6.46B$838.69MN/A2,300

Related Companies and Tools


This page (NASDAQ:EXPO) was last updated on 10/10/2026 by MarketBeat.com Staff.
From Our Partners